Tower Research Capital LLC (TRC) - EFFECTOR THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,400
-14.2%
12,334
+18.8%
0.00%
Q2 2023$8,620
+215400.0%
10,385
+0.7%
0.00%
Q1 2023$4
-60.0%
10,316
-54.6%
0.00%
Q4 2022$10
-99.9%
22,728
+38.5%
0.00%
Q3 2022$9,000
-18.2%
16,407
+119.4%
0.00%
Q2 2022$11,000
+450.0%
7,478
+1264.6%
0.00%
Q1 2022$2,000
-71.4%
548
-25.6%
0.00%
Q4 2021$7,000
-92.8%
737
-89.3%
0.00%
-100.0%
Q3 2021$97,0006,8590.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders